Defence Therapeutics Inc. (DTC.CN)

CAD 0.52

(0.0%)

Revenue Summary of Defence Therapeutics Inc.

  • Defence Therapeutics Inc.'s latest annual revenue in 2023 was - CAD , down 0.0% from previous year.
  • Defence Therapeutics Inc.'s latest quarterly revenue in 2023 Q3 was - CAD , down 0.0% from previous quarter.
  • Defence Therapeutics Inc. reported a annual revenue of - CAD in annual revenue 2022, down 0.0% from previous year.
  • Defence Therapeutics Inc. reported a annual revenue of - CAD in annual revenue 2021, down 0.0% from previous year.
  • Defence Therapeutics Inc. reported a quarterly revenue of - CAD for 2023 Q4, down 0.0% from previous quarter.
  • Defence Therapeutics Inc. reported a quarterly revenue of - CAD for 2023 Q1, down 0.0% from previous quarter.

Annual Revenue Chart of Defence Therapeutics Inc. (2023 - 2018)

Historical Annual Revenue of Defence Therapeutics Inc. (2023 - 2018)

Year Revenue Revenue Growth
2023 - CAD 0.0%
2022 - CAD 0.0%
2021 - CAD 0.0%
2020 - CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%

Peer Revenue Comparison of Defence Therapeutics Inc.

Name Revenue Revenue Difference
Algernon Pharmaceuticals Inc. - CAD NaN%
Asep Medical Holdings Inc 21.14 Thousand CAD 100.0%
BetterLife Pharma Inc. - CAD NaN%
BioVaxys Technology Corp. - CAD NaN%
ChitogenX Inc. - CAD NaN%
Rapid Dose Therapeutics Corp. 1.02 Million CAD 100.0%
Entheon Biomedical Corp. 250.32 Thousand CAD 100.0%
Gemina Laboratories Ltd. - CAD NaN%
Glow Lifetech Corp. 43.93 Thousand CAD 100.0%
Lexston Life Sciences Corp. - CAD NaN%
Pharmala Biotech Holdings Inc. 532 Thousand CAD 100.0%
Doseology Sciences Inc. 98.52 Thousand CAD 100.0%
MYND Life Sciences Inc. - CAD NaN%
Nova Mentis Life Science Corp. 28.34 Thousand CAD 100.0%
PharmaTher Holdings Ltd. - CAD NaN%
PreveCeutical Medical Inc. - CAD NaN%
Telescope Innovations Corp. 595.39 Thousand CAD 100.0%